Anna R. McCarthy

1.7k total citations
24 papers, 1.2k citations indexed

About

Anna R. McCarthy is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Anna R. McCarthy has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Geriatrics and Gerontology. Recurrent topics in Anna R. McCarthy's work include Sirtuins and Resveratrol in Medicine (5 papers), Autophagy in Disease and Therapy (5 papers) and Cancer-related Molecular Pathways (4 papers). Anna R. McCarthy is often cited by papers focused on Sirtuins and Resveratrol in Medicine (5 papers), Autophagy in Disease and Therapy (5 papers) and Cancer-related Molecular Pathways (4 papers). Anna R. McCarthy collaborates with scholars based in United Kingdom, Sweden and United States. Anna R. McCarthy's co-authors include Sonia Laı́n, Nicholas J. Westwood, Johanna Campbell, Maureen Higgins, David P. Lane, Jonathan J. Hollick, Oliver Staples, Virginia Appleyard, Andrew D. Abell and Karen Murray and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Cancer Cell.

In The Last Decade

Anna R. McCarthy

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna R. McCarthy United Kingdom 12 592 379 333 277 125 24 1.2k
Karen Murray United Kingdom 13 427 0.7× 230 0.6× 335 1.0× 206 0.7× 72 0.6× 20 971
Kevin G. Hoff United States 19 1.4k 2.3× 168 0.4× 103 0.3× 117 0.4× 95 0.8× 22 2.1k
Jeanette Seiler Germany 13 733 1.2× 121 0.3× 118 0.4× 90 0.3× 34 0.3× 15 1.0k
Jianguo Yang China 26 1.7k 2.9× 191 0.5× 274 0.8× 174 0.6× 60 0.5× 46 2.4k
Bárbara H. Zimmermann United States 15 1.0k 1.7× 115 0.3× 100 0.3× 151 0.5× 27 0.2× 28 1.5k
Leila Su United States 14 514 0.9× 100 0.3× 183 0.5× 97 0.4× 18 0.1× 19 851
Annette Biederbick Germany 9 532 0.9× 33 0.1× 73 0.2× 450 1.6× 136 1.1× 10 1.0k
R. Hermann Germany 8 464 0.8× 46 0.1× 59 0.2× 431 1.6× 77 0.6× 15 837
Clifford Young Australia 18 1.3k 2.2× 30 0.1× 510 1.5× 116 0.4× 77 0.6× 42 1.8k

Countries citing papers authored by Anna R. McCarthy

Since Specialization
Citations

This map shows the geographic impact of Anna R. McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna R. McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna R. McCarthy more than expected).

Fields of papers citing papers by Anna R. McCarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna R. McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna R. McCarthy. The network helps show where Anna R. McCarthy may publish in the future.

Co-authorship network of co-authors of Anna R. McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Anna R. McCarthy. A scholar is included among the top collaborators of Anna R. McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna R. McCarthy. Anna R. McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perkins, Janet, Sarah Nelson, Marshall Dozier, et al.. (2024). Is qualitative social research in global health fulfilling its potential?: a systematic evidence mapping of research on point-of-care testing in low- and middle-income contexts. BMC Health Services Research. 24(1). 172–172. 1 indexed citations
2.
McCarthy, Anna R.. (2020). Ambient Television.
3.
Ladds, Marcus J.G.W., Ingeborg M.M. van Leeuwen, Kai Er Eng, et al.. (2018). Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib. PLoS ONE. 13(4). e0195956–e0195956. 4 indexed citations
4.
McCarthy, Anna R.. (2016). Clutter and Clodder. Social Text. 34(3). 127–129. 1 indexed citations
5.
Schölz, Christian, Brian T. Weinert, Sebastian Wagner, et al.. (2015). Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nature Biotechnology. 33(4). 415–423. 220 indexed citations
6.
Stafford, William C., Catherine J. Drummond, Anna R. McCarthy, et al.. (2015). Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells. Oncotarget. 6(18). 16488–16506. 27 indexed citations
7.
McCarthy, Anna R., Maureen Higgins, Johanna Campbell, et al.. (2013). Tenovin-D3, a Novel Small-Molecule Inhibitor of Sirtuin SirT2, Increases p21 ( CDKN1A ) Expression in a p53-Independent Manner. Molecular Cancer Therapeutics. 12(4). 352–360. 36 indexed citations
8.
Leeuwen, Ingeborg M.M. van, et al.. (2013). Modulation of p53 C-Terminal Acetylation by mdm2, p14ARF, and Cytoplasmic SirT2. Molecular Cancer Therapeutics. 12(4). 471–480. 30 indexed citations
9.
McCarthy, Anna R., Lisa Pirrie, Jonathan J. Hollick, et al.. (2012). Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. Bioorganic & Medicinal Chemistry. 20(5). 1779–1793. 50 indexed citations
10.
Galvin, Paul, Damien Thompson, Katie B. Ryan, et al.. (2011). Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications. Cellular and Molecular Life Sciences. 69(3). 389–404. 80 indexed citations
11.
Leeuwen, Ingeborg M.M. van, Maureen Higgins, Johanna Campbell, et al.. (2011). Mechanism-specific signatures for small-molecule p53 activators. Cell Cycle. 10(10). 1590–1598. 42 indexed citations
12.
McCarthy, Anna R., Jonathan J. Hollick, & Nicholas J. Westwood. (2010). The discovery of nongenotoxic activators of p53: Building on a cell-based high-throughput screen. Seminars in Cancer Biology. 20(1). 40–45. 9 indexed citations
13.
Edwards, Brent Hayes, Anna R. McCarthy, & Randy Martín. (2009). Collective. Social Text. 27(3). 74–77.
14.
Edwards, Brent Hayes & Anna R. McCarthy. (2009). Introduction. Social Text. 27(3). 1–24. 1 indexed citations
15.
McCarthy, Anna R.. (2009). Film and Mass Culture. Social Text. 27(3). 129–133. 1 indexed citations
16.
Staples, Oliver, Jonathan J. Hollick, Johanna Campbell, et al.. (2008). Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen. Cell Cycle. 7(21). 3417–3427. 12 indexed citations
17.
Laı́n, Sonia, Jonathan J. Hollick, Johanna Campbell, et al.. (2008). Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator. Cancer Cell. 13(5). 454–463. 419 indexed citations
18.
Laı́n, Sonia, Jonathan J. Hollick, Johanna Campbell, et al.. (2007). Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Molecular Cancer Therapeutics. 6(12). 3 indexed citations
19.
McCarthy, Anna R., Rolf W. Hartmann, & Andrew D. Abell. (2007). Evaluation of 4′-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5α-reductase. Bioorganic & Medicinal Chemistry Letters. 17(13). 3603–3607. 11 indexed citations
20.
McCarthy, Anna R., Barbara Thomson, Ian C. Shaw, & Andrew D. Abell. (2005). Estrogenicity of pyrethroid insecticidemetabolites. Journal of Environmental Monitoring. 8(1). 197–202. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Murray Breakdown of academic impact, for papers by Kevin G. Hoff Breakdown of academic impact, for papers by Jeanette Seiler Breakdown of academic impact, for papers by Jianguo Yang Breakdown of academic impact, for papers by Bárbara H. Zimmermann Breakdown of academic impact, for papers by Leila Su Breakdown of academic impact, for papers by Annette Biederbick Breakdown of academic impact, for papers by R. Hermann Breakdown of academic impact, for papers by Clifford Young
Rankless by CCL
2026